Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT05309018
Eligibility Criteria:
Inclusion Criteria:
* Patient with AML
* Treated with a new targeted oral therapy as monotherapy or in combination:
* Venetoclax\* in combination with ivosidenib (IDH1 inhibitor)
* Onureg\* (azacitin: pyrimidine analogue)
* Venetoclax (BCL-2 protein inhibitor) in combination with subcutaneous azacitin
* Whose follow-up is provided alternately by a hematologist and an IPA.
* Affiliated to a social security scheme
Exclusion Criteria:
* Moderate or severe cognitive impairment
* Language barrier
* Other communication disorders
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05309018
Study Brief:
Protocol Section:
NCT05309018